Study investigates SARS-CoV-2 escape from nirmatrelvir

Researchers assessed SARS-CoV-2 Alpha, Delta, and Omicron variants’ resistance to nirmatrelvir, a protease inhibitor of SARS-CoV-2.

Related Keywords

Wuhan ,Hubei ,China ,Juan Gaertner Shutterstock , ,Nirmatrelvir Resistant ,High Fitness ,Image Credit ,Coronavirus Disease Covid 19 ,Cars ,Ars Cov 2 ,Fell ,Cell Culture ,Coronavirus ,Covid 19 ,Drugs ,Efficacy ,Hepatitis ,Hepatitis B ,Shiv ,Mmunodeficiency ,N Vitro ,Influenza ,Olecule ,Utation ,Micron ,Protein ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,Virus ,